Diabetes Care Devices – Market Insights – Europe

The COVID-19 pandemic has had a negative impact on the growth of the European diabetes care device market in the short term. However, the market is projected to be driven by the introduction of new technologies, trends such as remote patient monitoring, and the adoption of innovative products like hybrid closed-loop insulin pumps and patch pumps. These advanced products are anticipated to command higher prices and contribute to moderate growth over the forecast period.

This Medtech 360 Report provides comprehensive data and analysis on the state of the diabetes care device market in Europe from 2019 through 2032.

The COVID-19 pandemic has had a minimal impact on the diabetes care device market.

To what extent did COVID-19 pandemic impact the diabetes care device market in Europe?

Which device segment was most severely impacted by COVID-19?

When will the market exhibit pre-pandemic growth?

Technological advancements and innovations in the insulin pump device space will drive market growth.

What impact does the introduction of the hybrid closed-loop insulin pump system have on the market?

Which companies are positioned to capitalize on the expanding market and pursue new opportunities?

Several new competitors are anticipated to enter the diabetes care device market during the forecast period.

Which competitors are entering the market and what products are they introducing?

Which market segments are experiencing the highest influx of new competitors?

Various strategies are being implemented to capture market share and increase unit sales.

Who are the leading players in each device market?

What competitive advantages do these top competitors possess?

What is the future market outlook for these players?

Which companies are actively seeking to expand their product portfolios?

Table of contents